Recombinant human growth hormone and brain neoplasm association: a pharmacovigilance and Mendelian randomization analysis based on US FAERS, Japanese JADER, and Canadian CVARD
ObjectiveThis study aimed to analyze the statistical association between recombinant human growth hormone (rhGH) and brain neoplasm adverse events (AEs) by mining data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database, the Japanese Adverse Drug Event Report (JA...
Saved in:
| Main Authors: | Li Huang, Mei Zhang, Fang Li, Yinpeng Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1630843/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases
by: Luo Lv, et al.
Published: (2025-05-01) -
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
by: Siyu Lou, et al.
Published: (2025-01-01) -
Effect of Recombinant Human Growth Hormone (rhGH) Use on Genetic Methylation Patterns and Their Relationship with Body Composition in Small-for-Gestational-Age (SGA) Newborns
by: Juan M. Alfaro Velásquez, et al.
Published: (2025-05-01) -
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024
by: Siyu Lou, et al.
Published: (2025-06-01) -
Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)
by: Yang Yang, et al.
Published: (2025-04-01)